Organization
Abbott Laboratories
U.S. health care company, one of the major U.S. makers of infant formula in 1981.
- Wikidata
- Q306764
Connections 2
intervened in
- World Health Assembly vote on the infant formula code 23 Apr 1981 urged the White House to vote no Primary record 1
involved in
- Senate hearing on infant formula in developing nations its Ross Division president gave evidence Primary record 2
Timeline 1 date
- 23 Apr 1981 Abbott Laboratories intervened in World Health Assembly vote on the infant formula code
Proof 2 sources
-
Letter from Joseph S. Jenckes, Abbott Laboratories, to Lyn Nofziger, The White House, 23 April 1981 (Reagan Library, WHORM IT102, Box 36), Abbott Laboratories, 23 Apr 1981.
Primary record
The U.S. Government should not abstain from voting on this Code, but should strongly oppose the Code and vote
-
Marketing and Promotion of Infant Formula in the Developing Nations, 1978: hearing before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, 95th Congress, 2nd session, 23 May 1978, U.S. Congress, 23 May 1978.
Primary record
Archived copy
Cox, David O., president, Ross Division, Abbott Laboratories
Page history 1 change
- Add 55 stories, each checked against its sources96e92fe6
Something wrong or missing? Tell us, with a source, or edit this page.